| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,145 | 2,265 | 08:12 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| NIGHTINGALE HEALTH Aktie jetzt für 0€ handeln | |||||
| 02.07. | Nightingale Health Oyj: Inside information, profit warning: Nightingale Health's revenue increases, and adjusted EBITDA declines compared to the previous financial year | 94 | GlobeNewswire (Europe) | Nightingale Health Plc | Inside Information | July 02, 2025 at 12:55:00 EEST
Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF) estimates that it has exceeded its revenue target for the... ► Artikel lesen | |
| 30.06. | Nightingale Health Oyj: Nightingale Health's U.S. laboratory now open | 98 | GlobeNewswire (Europe) | Nightingale Health Plc | Press Release | June 30, 2025 at 17:15:00 EEST
Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), a pioneer in disease risk detection and preventative health... ► Artikel lesen | |
| 10.04. | Nightingale Health Oyj: Nightingale Health's laboratory implementation in the United States progresses as planned - opens first to medical research customers in Summer 2025 | 148 | GlobeNewswire (Europe) | Nightingale Health Plc | Press Release | April 10, 2025 at 09:30:00 EEST
Nightingale Health Plc
Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF) a pioneer in disease risk detection... ► Artikel lesen | |
| 25.03. | Citi Appointed as Depositary Bank for Nightingale Health OYJ's ADR Program | 367 | Business Wire | Citi Issuer Services, acting through Citibank N.A., has been appointed by Nightingale Health OYJ ("Nightingale Health") to act as depositary bank for its sponsored Level 1 American Depositary Receipt... ► Artikel lesen | |
| 21.03. | Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US | 1 | Cision News | ||
| 21.03. | OTC Markets Group Welcomes NIGHTINGALE HEALTH OYJ to OTCQX | 1 | GlobeNewswire (USA) | ||
| 19.03. | Nasdaq Helsinki welcomes Nightingale Health to Main Market | 192 | GlobeNewswire | 19 March 2025, Helsinki - Nasdaq (Nasdaq: NDAQ) announces that trading in Nightingale Health Plc shares (ticker: HEALTH) will commence today on the Main Market of Nasdaq Helsinki. Nightingale Health... ► Artikel lesen | |
| 18.03. | Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025 | 1 | Cision News | ||
| 18.03. | Nightingale Health Plc: Move From Nasdaq First North Growth Market Finland To The Official List | 185 | GlobeNewswire | EXCHANGE NOTICE, 18 MARCH 2025 SHARES
NIGHTINGALE HEALTH PLC: MOVE FROM NASDAQ FIRST NORTH GROWTH MARKET FINLAND TO THE OFFICIAL LIST
At the request of Nightingale Health Plc, the... ► Artikel lesen | |
| 17.03. | The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus | 1 | Cision News | ||
| 17.03. | Nightingale Health Oyj: Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the ... | 270 | GlobeNewswire (Europe) | Nightingale Health Plc
Stock exchange release
17 March 2025 at 1:55 p.m. (EET)Nightingale Health Plc ("Nightingale Health" or the "Company") announced on 27 November 2024 that it was investigating... ► Artikel lesen | |
| 06.03. | Nightingale Health Oyj: Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States | 415 | GlobeNewswire (Europe) | Nightingale Health Group's Half-year report 1 July 2024 - 31 December 2024 (unaudited) Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States
Company... ► Artikel lesen | |
| 07.02. | Nightingale Health Oyj: Nightingale Health announces its updated regulatory plan in the United States | 258 | GlobeNewswire (Europe) | Nightingale Health Plc
Press release
7 February 2025 at 2:15 p.m. (EET)Nightingale Health Plc ("Nightingale Health"), a pioneer in disease risk detection and preventative health announces its regulatory... ► Artikel lesen | |
| 20.09.24 | Nightingale Health Oyj: Nightingale Health Plc Financial Statements Release 1 July 2023 - 30 June 2024 | 148 | GlobeNewswire (Europe) | Nightingale Health Plc
Company release
20 September 2024 at 9:00 a.m. (EEST)Nightingale Health Group's Financial Statements Release 1 July 2023 - 30 June 2024 (unaudited) Nightingale's Financial Statements... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 390,80 | +0,64 % | Medtronic: Hugo der Hoffnungsträger - Kampfansage an Intuitive Surgical | In immer mehr Kliniken kommen OP-Roboter zum Einsatz, allen voran bei chirurgischen Eingriffen. Hier führt am Branchenprimus Intuitive Surgical mit den innovativen Da-Vinci-Operationssystemen kein Weg... ► Artikel lesen | |
| RHOEN-KLINIKUM | 11,700 | -0,85 % | RHÖN-KLINIKUM Campus Bad Neustadt erneut als Schwerpunktzentrum Hypertonie zertifiziert | Bad Neustadt a.d. Saale (ots) - Die Klinik für kardiologische Rehabilitation am RHÖN-KLINIKUM Campus Bad Neustadt wurde erneut von der Deutschen Hochdruckliga e. V. (DHL®) als "Schwerpunktzentrum Hypertonie"... ► Artikel lesen | |
| BICO GROUP | 2,124 | -0,09 % | Schock-News für Bico Group Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| M1 KLINIKEN | 13,520 | -1,31 % | EQS-News: M1 Kliniken AG: Erfolgreiches 1. Halbjahr 2025 mit EBIT-Wachstum von 24% und Ergebnis je Aktie von 0,63EUR | EQS-News: M1 Kliniken AG
/ Schlagwort(e): Halbjahresergebnis/Quartalsergebnis
M1 Kliniken AG: Erfolgreiches 1. Halbjahr 2025 mit EBIT-Wachstum von 24% und Ergebnis je Aktie von... ► Artikel lesen | |
| BAXTER | 20,685 | -0,89 % | Dividendenbekanntmachungen (29.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,34 USD 0,2911 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,18 USD 0,1541 EUR AEBI SCHMIDT HOLDING... ► Artikel lesen | |
| JD HEALTH INTERNATIONAL | 7,650 | 0,00 % | JD Health: Chinas größter Online-Gesundheitsdienstleister ist sehr gut unterwegs | JD Health wächst rasant: Mit Künstlicher Intelligenz, strategischen Partnerschaften und einem boomenden Markt setzt das Unternehmen neue Maßstäbe im digitalen Gesundheitssektor. JD Health International... ► Artikel lesen | |
| LIFEWARD | 0,574 | 0,00 % | Lifeward Ltd.: Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| COOPER COMPANIES | 58,00 | -0,85 % | Cooper Companies stock rating reiterated by Stifel at Buy with $85 target | ||
| COMMUNITY HEALTH SYSTEMS | 2,460 | 0,00 % | COMMUNITY HEALTH SYSTEMS INC - 8-K, Current Report | ||
| RAMSAY HEALTH CARE | 18,700 | 0,00 % | RAMSAY HEALTH CARE LIMITED: Response to ASX Aware Letter | ||
| ONWARD MEDICAL | 5,150 | 0,00 % | ONWARD Medical NV: ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
The CE Mark certification allows marketing for both clinic and... ► Artikel lesen | |
| SAVARIA | 12,700 | -0,78 % | Savaria Corporation declares CAD 0.045 dividend | ||
| SENSUS HEALTHCARE | 2,740 | -1,44 % | Sensus Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| SONIDA SENIOR LIVING | 21,800 | 0,00 % | Sonida signals pursuit of $100M NOI with record occupancy and accelerated acquisition integration | ||
| XVIVO PERFUSION | 15,790 | 0,00 % | Nomination Committee of XVIVO Perfusion AB | GOTHENBURG, SWEDEN / ACCESS Newswire / September 5, 2025 / The following members have been appointed to XVIVO Perfusion's (STO:XVIVO)(LSE:0RKL)(FRA:3XV) nomination committee for the 2026 annual general... ► Artikel lesen |